Researchers at the University of Illinois and the Agency for Science, Technology & Research in Singapore are using the gene-editing tool CRISPR-Cas9 to uncover potentially useful drug compounds.
The team has used CRISPR-Cas9 to turn on “silent” gene clusters in Streptomyces and express genes that naturally produce drug compounds to be used as antibiotics or anti-cancer agents. Their work was published in Nature Chemical Biology.
Get the full story at our sister site, Drug Delivery Business News.
The post CRISPR uncovers drug compounds in bacterial genome appeared first on MassDevice.